Clinical Trials Browser

Phase 2 × Disease Progression × liposomal doxorubicin × Clear all

NCT03804866 2019-01-15

NGR-hTNF in Combination With an Anthracycline in Platinum-resistant Ovarian Cancer (NGR018)

Phase 2 Completed

Neoplasm Metastasis, Ovarian Neoplasms, Disease Progression

NCT01358071 2018-09-27

NGR018

Phase 2 Completed

Neoplasm Metastasis, Ovarian Neoplasms, Disease Progression